Association between hypertension and fragility fracture: a longitudinal study
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Hypertension is an independent risk factor for osteoporosis and osteoporotic fracture in postmenopausal women.
Although hypertension has been suggested to be associated with increased fracture risk, it is not clear whether the association is independent of bone mineral density (BMD). The present study sought to examine the interrelationships between hypertension, BMD, and fracture risk.
The study included 1,032 men and 1,701 women aged 50 years and older who were participants in the Dubbo Osteoporosis Epidemiology Study. BMD at the femoral neck and lumbar spine was measured by dual energy X-ray absorptiometry (GE-LUNAR Corp., Madison, WI, USA). The presence of hypertension was ascertained by direct interview and verification through clinical history. The incidence of fragility fractures was ascertained by X-ray report during the follow-up period (1989–2008). The Cox proportional hazards model was used to assess the association between hypertension and fracture risk.
Women with hypertension had lower BMD at the femoral neck (0.79 versus 0.82 g/cm2, P = 0.02) than those without the disease. After adjusting for BMD and covariates, hypertension was an independent risk factor for fragility fracture [hazard ratio (HR), 1.49; 95 % CI, 1.13–1.96]. In men, hypertension was associated with higher femoral neck BMD (0.94 versus 0.92 g/cm2, P = 0.02), but the association between hypertension and fracture risk did not reach statistical significance.
Hypertension is associated with increased fracture risk in women, and the association is independent of BMD.
- Association between hypertension and fragility fracture: a longitudinal study
Volume 25, Issue 1 , pp 97-103
- Cover Date
- Print ISSN
- Online ISSN
- Springer London
- Additional Links
- Bone mineral density
- Fracture risk
- Industry Sectors
- Author Affiliations
- 1. Division of Musculoskeletal Diseases, Garvan Institute of Medical Research, 384 Victoria Street, Sydney, New South Wales, 2010, Australia
- 2. School of Public Health & Community Medicine, University of New South Wales, Sydney, Australia
- 5. Department of Endocrinology, St. Vincent’s Hospital, Sydney, Australia
- 3. St. Vincent’s Clinical School, University of New South Wales, Sydney, Australia
- 4. School of Medicine, The University of Notre Dame Australia, Fremantle, Australia